CAR-T: Technology, Process, and Validation Student Poster Competition
April 16, 2019
Rutgers University, Richard Weeks Hall of Engineering,Busch Campus
Piscataway, NJ
Presentation
Chimeric antigen receptor (CAR) T cell therapies are being investigated to provide patients with hematologic cancers an alternative treatment using the immune system. These biological products are unique in that they are produced by adding chimeric antigen receptors (CARs) to a patient’s T cells; the CAR can recognize and attack cells that display particular protein (antigen), including cancer cells.
The author will present a high level summary of CAR T cell therapy, basic considerations during process development and process validation activities.
Speaker:
Dr. Humberto Vega, Sr. Director of Celgene, S12 CAR T Manufacturing Science & Technology, Summit, NJ
Agenda:
- 2:30pm - 3:45pm Students arrive and set-up
- 4:00pm - 5:45pm Student Poster Judging
- 4:45pm - 5:45pm Networking Reception
- 6:00pm - 7:00pm Presentation
"CAR-T: Technology, Process. and Validation" by Humberto Vega, PhD, Celgene - 7:00pm - 7:30pm Awards
- 7:30pm - 8:00pm Wrap up and Conclusion
Cost:
- Members - $40
- Non-Members - $50
- Young Professionals - $20
- Student Members - FREE
Bring a non-member guest and receive a $25 gift card!
Sponsorship's Available:
Silver Sponsor - $250
One free registration, recognition on announcements, at the event, in newsletter
Gold Sponsor - $500
Two free registrations, recognition on announcements, at the event, in newsletter
Sponsor early for the maximum exposure!
Feel free to forward this to your colleagues